Skip to Main Content

Paper Details

Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis.
Nat Biotechnol
43
2023
Author NameAffiliation
Hans CleversHubrecht Institute, Royal Netherlands Academy of Arts and Sciences
Hans CleversOncode Institute
Hans CleversThe Princess Maxima Center for Pediatric Oncology
Hans CleversUniversity Medical Center Utrecht
Hans CleversResearch and Early Development of F. Hoffmann-La Roche Ltd
  • 1 - 5

Datasets

Release 1.2